---
title: "Peri-procedural Costs of Thromboembolic vs Bleeding Events in DOAC-treated Patients Undergoing Hig"
id: "medrxiv-1-peri-procedural-healthcare-costs-of-thromboembolic-and-bleeding-events-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-peri-procedural-healthcare-costs-of-thromboembolic-and-bleeding-events-in"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1?rss=1"
published_at: "2026-08-03T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Peri-procedural Costs of Thromboembolic vs Bleeding Events in DOAC-treated Patients Undergoing Hig
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-peri-procedural-healthcare-costs-of-thromboembolic-and-bleeding-events-in
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1?rss=1)
- **Published At:** 2026-08-03T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective cohort study used the TriNetX Linked Claims database (2015–2025) to quantify peri-procedural adverse event rates and incremental 90-day healthcare costs among adults on **direct oral anticoagulants (DOACs)** or warfarin who underwent **high-risk endoscopy**. - The analytic sample included 2,486 unique anticoagulated patients; cost data were available for 1,933 of these. Median age was 65 years; 61.5% were male and 81% had atrial fibrillation. - Peri-procedural **bleeding** occurred in 18.0% of patients within 7 days and 22.9% within 90 days after the index procedure. - **Thromboembolic events** (stroke/TIA) were less common: 0.5% at 7 days and 1.7% at 90 days. - Cost analysis used principal-diagnosis billing codes from acute-care encounters (ED or inpatient) within 90 days and compared unadjusted and multivariable-adjusted incremental 90-day costs using generalized linear models. - A single **stroke/TIA** event incurred substantially higher costs than a bleeding event: unadjusted incremental cost +$8,874 and adjusted +$5,798 (cost ratio 1.56; 95% CI 1.11–2.20; p=0.011). - A single **bleeding** event added $3,471 unadjusted and $3,157 adjusted (cost ratio 1.33; 95% CI 1.18–1.50; p<0.001). - Patients who experienced both bleeding and a subsequent stroke/TIA had the highest mean 90-day costs ($23,716). - The authors conclude that peri-procedural **thromboembolic events** cost approximately 2.5-fold more per event than bleeding, highlighting the clinical and economic importance of peri-procedural DOAC management and the need for randomized data on optimal DOAC resumption timing. - This report is a preprint and has not been peer reviewed; individual patient-level data cannot be shared due to the data use agreement, though code and pre-registration materials are publicly available.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=a4lyJIVRxDY1ENscxlayQP2p3tZe6EcTb7Cq3WIDXig-1785780370.408538-1.2.1.1-iSiJK_cn_ALOv7_iX9iqeAkuzHFkabdyZ0wBdPR3wss) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Peri-Procedural Healthcare Costs of Thromboembolic and Bleeding Events in Patients on Direct Oral Anticoagulants Undergoing High-Risk Endoscopy [ View ORCID Profile](http://orcid.org/0000-0002-0306-8364)Zachary L Smith, Nauzer Forbes, B. Joseph Elmunzer, Denise Scholtens, Christian T Ruff doi: https://doi.org/10.64898/2026.07.31.26359377 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Zachary L Smith 1 Medical College of Wisconsin; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zachary%2BL%2BSmith%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Smith%20ZL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AZachary%2BL%2BSmith%2B) * [ORCID record for Zachary L Smith](http://orcid.org/0000-0002-0306-8364 "Open in new tab") * For correspondence: zsmith@mcw.edu Nauzer Forbes 2 University of Calgary; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nauzer%2BForbes%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Forbes%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANauzer%2BForbes%2B) B. Joseph Elmunzer 3 Atrium Health - Wake Forest University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=B.%2BJoseph%2BElmunzer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Elmunzer%20BJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AB.%2BJoseph%2BElmunzer%2B) Denise Scholtens 4 Northwestern University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Denise%2BScholtens%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Scholtens%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADenise%2BScholtens%2B) Christian T Ruff 5 Brigham and Women's Hospital / Harvard Medical School * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christian%2BT%2BRuff%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ruff%20CT&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristian%2BT%2BRuff%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1270635/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1270635/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1270635/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1270635/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1270635/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1270635/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract ABSTRACT Background and study aims: Patients on direct oral anticoagulants (DOACs) undergoing high-risk endoscopy face competing risks of bleeding and thromboembolism during peri-procedural anticoagulant interruption. We quantified peri-procedural adverse event (AE) rates and incremental healthcare costs. Patients and methods: Retrospective cohort study using the TriNetX Linked Claims database (2015-2025), a US-wide multi-payer claims network. Adults on DOAC or warfarin therapy who underwent high-risk endoscopy were included (N=2,486 unique patients; N=1,933 with linked cost data). Peri-procedural bleeding and thromboembolic events were identified using principal-diagnosis codes in acute care encounters (emergency department or inpatient) within 90 days of the index procedure. Unadjusted and multivariable-adjusted incremental 90-day costs were compared between patients with and without each AE type using generalized linear models. Results: Among 2,486 anticoagulated patients (median age 65; 61.5% male; 81% with atrial fibrillation), bleeding occurred in 18.0% at 7 days and 22.9% at 90 days. Stroke/TIA occurred in 0.5% at 7 days and 1.7% at 90 days. Each thromboembolic event cost approximately 2.5 times more than each bleeding event. Stroke/TIA added $8,874 unadjusted (p ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The study was pre-registered on Open Science Framework (https://doi.org/10.17605/OSF.IO/RK28Q). The analytic code is publicly available at the same registry. Due to the terms of the data use agreement between TriNetX and Medical College of Wisconsin, the individual patient-level dataset cannot be shared publicly. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.07.31.26359444v1 "Systematic investigation of gengetically determined plasma and urinary biomarkers to identify potential detection and intervention targets for vascular calcification")[Next ](https://www.medrxiv.org/content/10.64898/2026.07.28.26359105v1 "Statistical analysis of sexual dimorphism in adults of Western UP by Computed Tomography based Sternal Morphometry") Posted August 03, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/03/2026.07.31.26359377.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.07.31.26359377v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/03/2026.07.31.26359377.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Peri-Procedural Healthcare Costs of Thromboembolic and Bleeding Events in Patients on Direct Oral Anticoagulants Undergoing High-Risk Endoscopy Zachary L Smith, Nauzer Forbes, B. Joseph Elmunzer, Denise Scholtens, Christian T Ruff medRxiv 2026.07.31.26359377; doi: https://doi.org/10.64898/2026.07.31.26359377 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.31.26359377v1%26text%3DPeri-Procedural%2520Healthcare%2520Costs%2520of%2520Thromboembolic%2520and%2520Bleeding%2520Events%2520in%2520Patients%2520on%2520Direct%2520Oral%2520Anticoagulants%2520Undergoing%2520High-Risk%2520Endoscopy "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.31.26359377v1%26t%3DPeri-Procedural%2520Healthcare%2520Costs%2520of%2520Thromboembolic%2520and%2520Bleeding%2520Events%2520in%2520Patients%2520on%2520Direct%2520Oral%2520Anticoagulants%2520Undergoing%2520High-Risk%2520Endoscopy "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.31.26359377v1%26title%3DPeri-Procedural%2520Healthcare%2520Costs%2520of%2520Thromboembolic%2520and%2520Bleeding%2520Events%2520in%2520Patients%2520on%2520Direct%2520Oral%2520Anticoagulants%2520Undergoing%2520High-Risk%2520Endoscopy%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.31.26359377v1%26title%3DPeri-Procedural%2520Healthcare%2520Costs%2520of%2520Thromboembolic%2520and%2520Bleeding%2520Events%2520in%2520Patients%2520on%2520Direct%2520Oral%2520Anticoagulants%2520Undergoing%2520High-Risk%2520Endoscopy "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.07.31.26359377) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.07.31.26359377v1&count=horizontal&via=&text=Peri-Procedural%20Healthcare%20Costs%20of%20Thromboembolic%20and%20Bleeding%20Events%20in%20Patients%20on%20Direct%20Oral%20Anticoagulants%20Undergoing%20High-Risk%20Endoscopy&counturl=www.medrxiv.org/content/10.64898/2026.07.31.26359377v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (594) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (887) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (322) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4680) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (465) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (402) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (631) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1593) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15647) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1176) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6876) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (714) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1034) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4852) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1412) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1699) * [Hematology](https://www.medrxiv.org/collection/hematology) (568) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1304) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16145) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1144) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (650) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (148) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (704) * [Neurology](https://www.medrxiv.org/collection/neurology) (7026) * [Nursing](https://www.medrxiv.org/collection/nursing) (357) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1056) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1206) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (988) * [Oncology](https://www.medrxiv.org/collection/oncology) (3510) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1015) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (381) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (432) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (454) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (135) * [Pathology](https://www.medrxiv.org/collection/pathology) (695) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1752) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (724) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (751) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5721) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9551) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2324) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1406) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1227) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (628) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (756) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (567) * [Surgery](https://www.medrxiv.org/collection/surgery) (750) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (105) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (299) * [Urology](https://www.medrxiv.org/collection/urology) (278) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers abo
## Related Clinical Research

- [New oral anticoagulants linked to slower cognitive decline in Alzheimer’s patients with AFib](https://medichelpline.com/clinical-feed/medical-news-today-0-new-oral-anticoagulants-may-help-slow-cognitive-decline-in-alzheimer-s-disease.md)
- [Young-onset stroke in the UAE: risk factors, subtypes, and outcomes from a single-centre study](https://medichelpline.com/clinical-feed/plos-one-19-young-onset-stroke-in-the-uae-a-single-centre-retrospective-analysis-of-risk.md)
- [Widening medication adherence gap: impact on modern therapeutics and system solutions](https://medichelpline.com/clinical-feed/plos-medicine-0-the-widening-medication-adherence-gap.md)
- [Intensive blood pressure control linked to 15% lower 7-year dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-intensive-blood-pressure-control-cuts-7-year-dementia-risk-by-15-study-finds.md)
- [Field-of-view confounding in self-supervised cardiac imaging alters genetic discovery](https://medichelpline.com/clinical-feed/medrxiv-9-field-of-view-confounding-shapes-genetic-discovery-from-self-supervised-cardiac.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.